Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Opko Health (NY: OPK)
7.160 USD  +0.150 (+2.14%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Opko Health
 
< Previous 1 2 3 4 5 Next >
OPKO Announces First Quarter 2013 Operating and Financial Highlights
May 09, 2013
from Business Wire News Releases
New Market Report: OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2013 Update
May 03, 2013
from PRBuzz Press Release Distribution
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection With the Sale of the Company to OPKO Health, Inc.
May 02, 2013
from GlobeNewswire News Releases
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection with the Sale of the Company to OPKO Health
April 29, 2013
from PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection with the Sale of the Company to OPKO Health
April 26, 2013
from Business Wire News Releases
Free Research Reports on AMGN, OPK, SLAB and VOCS Issued by the Bedford Report
April 26, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of PROLOR Biotech, Inc. Shareholders
April 25, 2013
from Business Wire News Releases
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection with the Sale of the Company to OPKO Health
April 25, 2013
from Business Wire News Releases
PROLOR Biotech Investor Alert by Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates PROLOR Biotech, Inc. Following Announcement of Acquisition by OPKO Health, Inc. for Potential
April 24, 2013
from Business Wire News Releases
Acquisition of PROLOR Biotech, Inc. by OPKO Health, Inc. May Not Be in the Best Interests of PROLOR Shareholders
April 24, 2013
from PR Newswire
Management Buyout Of PROLOR - Law Firm Seeks Higher Price For Shareholders
April 24, 2013
from PR Newswire
OPKO Health To Acquire PROLOR Biotech
April 24, 2013
—Acquisition Adds Promising Late Stage Product hGH-CTP Targeting Growth Hormone Deficiency and Preclinical Products Targeting Hemophilia, Obesity & Diabetes— Read More
from PR Newswire
Free Research Reports on CNX, CY, OPK and PEP Issued by the Paragon Report
April 19, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
OPKO Health Acquires Interest in Growing Russian Pharmaceutical Company
April 18, 2013
from Business Wire News Releases
Opko Health, Accuray, Medicines, DaVita, and DENTSPLY Intl. Early Briefing and Review
April 15, 2013
from PR Newswire
OPKO Health Announces Publication of Study Detecting Antibodies in NMO Patients Using OPKO Screening Technology
April 05, 2013
from Business Wire News Releases
Prescription for Success: Commercialization Efforts, Acquisitions and Enhanced Patent Protection - Research Report on PAREXEL International, Ironwood Pharmaceuticals, Opko Health, Amarin Corporation,
March 19, 2013
from PR Newswire
Bio Stocks Traders Are Looking For: (NYSE: OPK), (OTCQB: MDXG)
March 18, 2013
from SBWire Direct - Latest Press Releases
Pre-Market Analysis on MGIC Investment, Ultra Petroleum, Opko Health, and Accuray
March 15, 2013
from PR Newswire
RXi Pharmaceuticals and OPKO Health Announce Strategic Pooling of RNAi Assets
March 07, 2013
from Business Wire News Releases
RXi Pharmaceuticals Announces $16.4 Million Placement of Common Stock
March 07, 2013
from Business Wire News Releases
RXi Pharmaceuticals and OPKO Health Announce Strategic Pooling of RNAi Assets
March 07, 2013
from Business Wire News Releases
RXi Pharmaceuticals Announces $16.4 Million Placement of Common Stock
March 07, 2013
from Business Wire News Releases
OPKO Health Completes Acquisition of Two Phase 3 Products
March 04, 2013
from Business Wire News Releases
OPKO Point-of-Care Technology Demonstrated on Mobile Device with Cloud Connectivity to Diagnose and Track Disease in Africa
March 01, 2013
from Business Wire News Releases
Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High
February 19, 2013
RDInvesting Provides Stocks Research on Opko Health and Questcor Pharmaceuticals Read More
from Marketwired News Releases
OPKO Health Completes Acquisition of Brazilian Pharmaceutical Company
February 15, 2013
from Business Wire News Releases
Should Recent Insider Buying on YUM, OPK, ASBC and TDG Matter to You?
February 11, 2013
from Marketwired News Releases
Clarification Regarding Exercise and Sale of Common Stock Options by OPKO Health Company Officer
February 08, 2013
from Business Wire News Releases
Trend Analysis Reports on Stocks to Watch Closely: (NYSE: OPK), (NASDAQ: BGCP)
February 05, 2013
from SBWire Direct - Latest Press Releases
< Previous 1 2 3 4 5 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here



Recent News






Portions of this content may be copy written by Fresh Brewed Media, Investors Observer, and/or O2 Media LLC. SmartReadMX and other related related technologies used to produce content for this service are covered by US Patents numbers 7,865,496, 7,856,390, and 7,716,116.